Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus

被引：0

作者：

Sandra P Frizelle

Jeffrey B Rubins

Joan X Zhou

David T Curiel

Robert A Kratzke

机构：

[1] Minneapolis Veterans Affairs Medical Center,The Department of Medicine and Research Service

[2] University of Minnesota Medical School,Department of Medicine

[3] Pulmonary and Critical Care Medicine,Department of Medicine

[4] University of Minnesota Medical School,undefined

[5] Gene Therapy Program,undefined

[6] University of Alabama,undefined

[7] Sections of Hematology/Oncology/Transplant,undefined

[8] University of Minnesota Medical School,undefined

来源：

Cancer Gene Therapy | 2000年 / 7卷

关键词：

p16; mesothelioma; tumor suppressor; gene therapy; cell cycle;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The absence of expression of the p16INK4a gene product is observed in virtually all mesothelioma tumors and cell lines, whereas wild-type pRB expression is maintained. We have examined the potential therapeutic role of re-expressing the p16INK4a gene product in mice with established human mesothelioma xenografts. Experiments using Adp16 treatments in mesothelioma xenografts demonstrated prolonged survival and potential cure following treatment with p16INK4a-based gene therapy. These results demonstrate that p16INK4a gene transfer may play a therapeutic role in the treatment of mesothelioma. Cancer Gene Therapy (2000) 7, 1421–1425

引用

页码：1421 / 1425

页数：4

共 50 条

[1] Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus
Frizelle, SP
Rubins, JB
Zhou, JX
Curiel, DT
Kratzke, RA
[J]. CANCER GENE THERAPY, 2000, 7 (11) : 1421 - 1425
[2] Inactivation of p16INK4a expression in malignant mesothelioma by methylation
Wong, L
Zhou, J
Anderson, D
Kratzke, RA
[J]. LUNG CANCER, 2002, 38 (02) : 131 - 136
[3] Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein
M Kim
Y Katayose
L Rojanala
S Shah
M Sgagias
L Jang
Y-J Jung
S-H Lee
S-G Hwang
K H Cowan
[J]. Cell Death & Differentiation, 2000, 7 : 706 - 711
[4] Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein
Kim, M
Katayose, Y
Rojanala, L
Shah, S
Sgagias, M
Jang, L
Jung, YJ
Lee, SH
Hwang, SG
Cowan, KH
[J]. CELL DEATH AND DIFFERENTIATION, 2000, 7 (08): : 706 - 711
[5] P16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer
Rocco, JW
Li, DQ
Liggett, WH
Duan, L
Saunders, JK
Sidransky, D
O'Malley, BW
[J]. CLINICAL CANCER RESEARCH, 1998, 4 (07) : 1697 - 1704
[6] Prognostic significance of promoter methylation of p16INK4A in pleural mesothelioma
Hiroshima, Kenzo
Yusa, Toshikazu
Niwa, Hiroshi
Ogawa, Hiroshi
Fujino, Michio
Kameya, Toru
Ito, Ichiro
Ozaki, Daisuke
Araki, Akinobu
Itami, Makiko
Suzuki, Makoto
Yoshino, Ichiro
Kawai, Toshiaki
Tada, Yuji
Shimada, Hideaki
Tagawa, Masatoshi
Nakatani, Yukio
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S760 - S761
[7] Infectious Recombinant Senecavirus A Expressing p16INK4A Protein
Gong, Wencheng
Zhao, Xiaoya
Tang, Xiaoyu
Gao, Long
Sun, Yuan
Ma, Jingyun
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
[8] Combination radiation and adenovirus-mediated p16INK4A gene therapy in a murine model for head and neck cancer
Rhee, JG
Li, D
O'Malley, BW
Suntharalingam, M
[J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2003, 65 (03): : 144 - 154
[9] p16INK4a gene abnormalities in multiple myeloma
McClure, RF
James, CD
Kurtin, PJ
Greipp, PR
[J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 143A - 143A
[10] Retrovirus-mediated delivery of p16INK4A for gene therapy of glioblastoma
Strauss, B
Fontes, R
Chippola, J
Costanzi-Strauss, E
[J]. FASEB JOURNAL, 1999, 13 (07): : A1545 - A1545

← 1 2 3 4 5 →